Massachusetts Institute of Technology
Sign in Create Account

Inside the Lab: Paul Chang, Ph.D.

Learn more about the Chang lab’s work to better understand a family of proteins called PARPs, and how blocking specific PARPs might be a promising target for cancer therapies.

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments. If you don’t have an account yet, sign up now!

June 13, 2011 12:19
All Rights Reserved (What is this?)
Additional Files

16705 times

More from The David H. Koch Institute for Integrative Cancer Research @MIT

David H. Koch, Director & Executive Vice President, Koch Industries

David H. Koch, Director & Execu...

Added over 7 years ago | 00:08:07 | 14890 views

Why Cancer Drugs Stop Working

Why Cancer Drugs Stop Working

Added over 7 years ago | 00:30:05 | 16960 views

SOLUTIONS with/in/sight: Understanding the Path to Personalized Cancer Care

SOLUTIONS with/in/sight: Understand...

Added over 2 years ago | 01:10:27 | 1840 views

2009 Koch Institute Symposium - Xiao-Jing Wang

2009 Koch Institute Symposium - Xia...

Added 6 years ago | 00:25:18 | 51554 views

Prostate Tissue Stem Cells and Cancer Progression

Prostate Tissue Stem Cells and Canc...

Added 5 years ago | 00:26:27 | 6867 views

Meiosis in Clay

Meiosis in Clay

Added almost 3 years ago | 00:02:19 | 1797 views